| 
            
                 
             | 
        
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/57 | (2006.01) | 
| A61K 38/57 | (2013.01) | ||
| C07K 14/81 | (2006.01) | ||
| A61P 31/16 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 31/16 | (2006.01) | ||
| C07K 14/8121 | (2013.01) | ||
| C07K 14/44 | (2006.01) | ||
| C07K 14/44 | (2013.01) | 
| (11) | Patento numeris | 4135756 | 
| (13) | Dokumento rūšis | T | 
| (96) | Europos patento paraiškos numeris | 21718158.5 | 
| Europos patento paraiškos padavimo data | 2021-04-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-02-22 | 
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-27 | 
| (46) | Apibrėžties vertimo paskelbimo data | 
| (86) | Numeris | PCT/EP2021/060098 | 
| Data | 2021-04-19 | 
| (87) | Numeris | WO 2021/209644 | 
| Data | 2021-10-21 | 
| (30) | Numeris | Data | Šalis | 
| 20170253 | 2020-04-17 | EP | |
| 202063011738 P | 2020-04-17 | US | 
| (72) | 
            
                 
                    
                    
                    
                    
                    GIANNETTI, Bruno , NL  
            
                
                    
                    
                    
                    
                    RELAN, Anurag , NL  
            
                
                    
                    
                    
                    
                    SCHAALE-MAASS, Juergen Ulrich , NL  
            
         | 
    
| (73) | 
            
                Pharming Intellectual Property B.V. ,
                Darwinweg 24, 2333 CR Leiden,
                NL
                 | 
    
| (54) | C1 ESTERASE INHIBITOR TO TREAT CORONAVIRAL INFECTION-RELATED RESPIRATORY DISTRESS | 
| C1 ESTERASE INHIBITOR TO TREAT CORONAVIRAL INFECTION-RELATED RESPIRATORY DISTRESS |